LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 92 of 166
Next
>>
>
2276 to 2300 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	PLX-4720	0.12	uM	LJP5	72	hr	1657	5379	5588	0.9628	0.9571
BT-20	PLX-4720	0.37	uM	LJP5	72	hr	1657	5485	5588	0.9816	0.9790
BT-20	PLX-4720	1.11	uM	LJP5	72	hr	1657	5517	5588	0.9873	0.9855
BT-20	PLX-4720	3.33	uM	LJP5	72	hr	1657	4095	5588	0.7329	0.6750
BT-20	PLX-4720	10	uM	LJP5	72	hr	1657	2924	5588	0.5234	0.3819
BT-20	Lapatinib	0.04	uM	LJP6	72	hr	1657	4984	5383	0.9258	0.9105
BT-20	Lapatinib	0.12	uM	LJP6	72	hr	1657	5262	5383	0.9770	0.9722
BT-20	Lapatinib	0.37	uM	LJP6	72	hr	1657	5384	5383	1.0007	1.0011
BT-20	Lapatinib	1.11	uM	LJP6	72	hr	1657	5117	5383	0.9507	0.9413
BT-20	Lapatinib	3.33	uM	LJP6	72	hr	1657	4868	5383	0.9041	0.8840
BT-20	Lapatinib	10	uM	LJP6	72	hr	1657	4252	5383	0.7908	0.7422
BT-20	Sirolimus	0.04	uM	LJP6	72	hr	1657	3525	5383	0.6554	0.5597
BT-20	Sirolimus	0.12	uM	LJP6	72	hr	1657	3617	5383	0.6724	0.5833
BT-20	Sirolimus	0.37	uM	LJP6	72	hr	1657	3629	5383	0.6752	0.5868
BT-20	Sirolimus	1.11	uM	LJP6	72	hr	1657	3685	5383	0.6853	0.6009
BT-20	Sirolimus	3.33	uM	LJP6	72	hr	1657	3676	5383	0.6839	0.5987
BT-20	Sirolimus	10	uM	LJP6	72	hr	1657	3799	5383	0.7058	0.6292
BT-20	ZSTK474	0.04	uM	LJP6	72	hr	1657	5377	5383	0.9997	1.0001
BT-20	ZSTK474	0.12	uM	LJP6	72	hr	1657	4895	5383	0.9102	0.8926
BT-20	ZSTK474	0.37	uM	LJP6	72	hr	1657	3379	5383	0.6290	0.5217
BT-20	ZSTK474	1.11	uM	LJP6	72	hr	1657	2187	5383	0.4063	0.1764
BT-20	ZSTK474	3.33	uM	LJP6	72	hr	1657	1697	5383	0.3153	0.0134
BT-20	ZSTK474	10	uM	LJP6	72	hr	1657	1543	5383	0.2861	-0.0439
BT-20	BX-912	0.04	uM	LJP5	72	hr	1657	5063	5588	0.9063	0.8906
BT-20	BX-912	0.12	uM	LJP5	72	hr	1657	5125	5588	0.9174	0.9041

|<
<<
Previous
Page 92 of 166
Next
>>
>
2276 to 2300 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)